Market Access Lead for Disease Modifying Drug Development

UCL and Cure Parkinson's


We are seeking a KTP Associate to lead the innovative Disease Modifying Drug Development project putting the latest academic research into practice.

The aim of the KTP project is to optimise routes to patients of potential drugs being developed by CP. Currently, no treatments reduce disease progression. CP identifies and trials interventions with the potential to slow, stop and even reverse the condition and needs to ensure that success is expedited to patients in the UK and globally.

This role offers a springboard to a career in both industry and academia to postgraduates and postdocs in Medical or Biotech Development and related disciplines. You will apply your project management skills to translate complex business and clinical data into a format suitable for a range of audiences and utilise your Business and Regulatory skills to better understand the market and the regulatory ecosystem about Parkison’s disease. A collaborative attitude and strong communication and networking skills are key as you will have the opportunity to build a wide network of contacts within the field of neurodegenerative conditions and may help in bringing new therapeutic options to the Parkinson’s community.  

This role meets the eligibility requirements for a skilled worker certificate of sponsorship or a global talent visa under UK Visas and Immigration legislation. Therefore, UCL welcomes applications from international applicants who require a visa.